Polymorphisms in Th1/Th2 Cytokine Genes, Hormone Replacement Therapy, and Risk of Non-Hodgkin Lymphoma
Gongjian Zhu, Yawei Zhang(Nanjing Agricultural University), Brian P. Leaderer(Yale University), Chris Kim(Yale University), Dongsheng Pan(Yale University), Xuezhong Chen(Guangdong University of Foreign Studies), Yingtai Chen(Shanghai Jiao Tong University), Stephen J. Chanock(National Cancer Institute), Nathaniel Rothman(National Institutes of Health), Qing Lan(National Institutes of Health), Tongzhang Zheng(Yale University), Peter Boyle(ZHAW Zurich University of Applied Sciences), Xiaofeng Bi(Chinese Academy of Medical Sciences & Peking Union Medical College), Theodore R. Holford(Yale University)
Cited by 6
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants
|Bioinformatics|2015|2.2k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies
|JNCI Journal of the National Cancer Institute|2004|1.8k